Cléry

Investor profile | Builders Republic

About

Cléry is the impact investment structure of David Guinard and Robin Ucelli, founders of the solar energy producer Photosol, created in Paris in 2022 after the sale of the majority of Photosol. It invests directly in the capital of startups, most often in Series A and alongside institutional funds, in areas where it sees an environmental or health impact: health and medical devices, climate (energy, packaging), agriculture, mobility, and space. It does not publish assets under management or check size ranges. The portfolio includes about fifteen companies, including Hepta Medical, joined during the €5.7M Series A led by Bpifrance in 2024 and followed on in 2026, Primaa, NeoFarm, inHeart, Netri, AdEchoTech, Onafis, Separative, Zeway, or the British company Notpla. For a founder in health or climate, it is a family shareholder from energy entrepreneurship, who supports alongside the funds.

Key facts

Type
Family Office
Stages
Seed,Series A
Sectors
Agritech, Life sciences, Healthcare, Energy, Climate/Cleantech/Greentech, Spacetech/Aerospace, Foodtech, Mobility & Transportation, Smart cities, B2B, Software/SaaS, Digital health
Headquarters
France
Offices
Paris
Geographic focus
France
Founded
2022

Track record

  • Portfolio companies: 15

Notable investments

Alatyr, carbo culture, clarity, inHeart, Primaa, Notpla

Funds by stage

Other funds investing at the same stages, list by list.

Funds by sector

The funds investing in each sector, based on their rounds over the last 36 months.